Skip to content

Effect of Exercise on gestational diabetes

Effects of resistance training and exercise in water on visfatin and insulin levels in women with gestational diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014031717035N1
Enrollment
45
Registered
2015-04-03
Start date
2015-01-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gesttational diabets. Diabetes mellitus arising in pregnancy, Gestational diabetes mellitus NOS

Interventions

Intervention 1: Control group: This group is not just any kind of sporting activity takes place in the routine treatment. Intervention 2: Intervention group: This group is for 8 weeks, 3 sessions of 4
Prevention
Control group: This group is not just any kind of sporting activity takes place in the routine treatment.
Intervention group: This group is for 8 weeks, 3 sessions of 45 minutes of physical activity per week (water sports and clubs) are given.

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: (Inclusion criteria: Women with gestational diabetes1; In the 21 to 28 weeks of their pregnancy; According to the guidelines of the American College of Obstetrics and Gynecology, they do not have any absolute prohibition of the exercise; Age: 20 to 35 years of age; they do not use smoking, drugs and alcohol; they are untrained Exclusion criteria: People with a history of proven infectious diseases and autoimmune diseases such as lupus Eratosthenes and rheumatoid arthritis, thyroid disease, epilepsy, high blood pressure, leg pain, cervical insufficiency, anemia or other blood disorders, bleeding during pregnancy, placenta previa, respiratory problems, heart disease or any heart disease, obesity or excessive weight loss and Any disease that can be prevented the exercise, have be excluded from the study)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Enterlucin serm. Timepoint: Before intervntion and after 8 weeks intervention. Method of measurement: Kit.;- Exercise intensity. Timepoint: Before intervntion and after 8 weeks intervention. Method of measurement: Is measured according to the Rating of perveived exertion (RPE).;Visfatin Serum. Timepoint: Before intervntion and after 8 weeks intervention. Method of measurement: Kit.;Insulin sensitivity. Timepoint: Before intervntion and after 8 weeks intervention. Method of measurement: Kit.;Glycosylated hemoglobin. Timepoint: Before intervntion and after 8 weeks intervention. Method of measurement: Kit.;Insulin resistance and serum glucose. Timepoint: Before intervntion and after 8 weeks intervention. Method of measurement: Kit.

Secondary

MeasureTime frame
Nutrition. Timepoint: Before the research began. Method of measurement: Fed with the same diet.;Activity level before sampling. Timepoint: Before the research began. Method of measurement: level of physical activity using a physical activity questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Nasebe kazemi

Shiraz University Of Medical Sciences

nasibe.kazemi@yahoo.com+98 71 3628 1591

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026